Zenith Pharmaceuticals Limited - Limited company - abbreviated - 11.6

Zenith Pharmaceuticals Limited - Limited company - abbreviated - 11.6


04510052 1.6.14 31.5.15 31.5.15 Company accounts Private Limited Company FY true false true false true false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure045100522014-05-31045100522015-05-31045100522014-06-012015-05-31045100522013-05-31045100522013-06-012014-05-31045100522014-05-3104510052ns12:England2014-06-012015-05-3104510052ns14:PoundSterling2014-06-012015-05-3104510052ns7:Director12014-06-012015-05-3104510052ns7:OrdinaryShareClass12014-06-012015-05-3104510052ns7:Director22014-06-012015-05-3104510052ns7:Director32014-06-012015-05-3104510052ns7:CompanySecretary2014-06-012015-05-3104510052ns7:RegisteredOffice2014-06-012015-05-3104510052ns7:MainBusiness2014-06-012015-05-3104510052ns7:EntityAccountantsOrAuditors2014-06-012015-05-3104510052ns7:OrdinaryShareClass12015-05-3104510052ns7:OrdinaryShareClass12014-05-31
REGISTERED NUMBER: 04510052 (England and Wales)















Abbreviated Unaudited Accounts for the Year Ended 31 May 2015

for

Zenith Pharmaceuticals Limited

Zenith Pharmaceuticals Limited (Registered number: 04510052)

Contents of the Abbreviated Accounts
for the Year Ended 31 May 2015










Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 3

Zenith Pharmaceuticals Limited

Company Information
for the Year Ended 31 May 2015







DIRECTORS: S Tate
Mrs M J Tate
R Warriner





SECRETARY: Mrs M J Tate





REGISTERED OFFICE: Jubilee House
3 The Drive
Great Warley
Brentwood
Essex
CM13 3FR





BUSINESS ADDRESS: New Abbey Court
51-53 Stert Street
Abingdon
Oxfordshire
OX14 3JF





REGISTERED NUMBER: 04510052 (England and Wales)





ACCOUNTANTS: Neville & Stocker
Jubilee House
3 The Drive
Great Warley
Brentwood
Essex
CM13 3FR

Zenith Pharmaceuticals Limited (Registered number: 04510052)

Abbreviated Balance Sheet
31 May 2015

2015 2014
Notes £    £   
CURRENT ASSETS
Debtors - 112
Cash at bank 17,207 17,309
17,207 17,421
CREDITORS
Amounts falling due within one year 13,276 15,713
NET CURRENT ASSETS 3,931 1,708
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,931

1,708

CAPITAL AND RESERVES
Called up share capital 2 112 112
Profit and loss account 3,819 1,596
SHAREHOLDERS' FUNDS 3,931 1,708

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2015.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2015 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 21 September 2015 and were signed on its behalf
by:





S Tate - Director


Zenith Pharmaceuticals Limited (Registered number: 04510052)

Notes to the Abbreviated Accounts
for the Year Ended 31 May 2015


1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover
Turnover represents net invoiced sales of goods, excluding value added tax.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

2. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2015 2014
value: £    £   
112 Ordinary £1 112 112